Newsfeeds Archive - Page 2 of 5

1 minute read

July 18, 8:15 AM

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office (USPTO) has issued a patent related to non-invasive nerve

ECOR

1 minute read

News

electroCore, Inc. Announces Distribution Agreement With Reliefband Technologies, LLC

By Happy Mohamed

July 13, 8:13 AM

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband, the first and only FDA cleared non-invasive neuromodulation

ECOR

2 minute read

NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation – Which Is Better To Alleviate Concussion Symptoms

By Vuk Zdinjak

July 6, 10:21 AM

electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain management and perfor

ECOR

2 minute read

Earnings

electroCore Earnings Perspective: Return On Capital Employed

By Benzinga Insights

May 11, 10:52 AM

electroCore (NASDAQ:ECOR) brought in sales totaling $2.78 million during Q1 according to data provided by Benzinga Pro. However,…

ECOR

1 minute read

Earnings

electroCore: Q1 Earnings Insights

By Benzinga Insights

May 3, 4:05 PM

electroCore (NASDAQ:ECOR) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:00 PM. Here’s what investors…

ECOR

2 minute read

National Institutes Of Health Awards 3-year, $6M Grant For Pivotal Clinical Trial Of gammaCore In Patients With Opioid Use Disorders

By Happy Mohamed

April 26, 8:24 AM

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has

ECOR

2 minute read

ElectroCore Announces Remittance Of Annual License Fee From Teijin For Certain Exclusive Rights In Japan

By Happy Mohamed

April 11, 8:12 AM

electroCore, Inc. (the "Company") (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Teijin Limited (Teijin), a global conglomerate based in Japan offering

ECOR

3 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

March 24, 1:30 PM

Gainers electroCore (NASDAQ:ECOR) shares increased by 27.9% to $5.47 during Friday’s regular session. As of 13:30 EST, electroCore’s…

APTX

1 minute read

HC Wainwright & Co. Reiterates Buy on electroCore, Raises Price Target to $7

By Benzinga Newsdesk

March 9, 3:04 PM

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates electroCore (NASDAQ:ECOR) with a Buy and raises the price target from $2.75 to $7.

ECOR

6 minute read

Earnings

Earnings Scheduled For March 8, 2023

By Benzinga Insights

March 8, 5:42 AM

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.

ABM

Latest news

electroCore Expands Intellectual Patent Portfolio For nVNS Technology

electroCore, Inc. Announces Distribution Agreement With Reliefband Technologies, LLC

NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation – Which Is Better To Alleviate Concussion Symptoms

electroCore Earnings Perspective: Return On Capital Employed

electroCore: Q1 Earnings Insights

National Institutes Of Health Awards 3-year, $6M Grant For Pivotal Clinical Trial Of gammaCore In Patients With Opioid Use Disorders

ElectroCore Announces Remittance Of Annual License Fee From Teijin For Certain Exclusive Rights In Japan

12 Health Care Stocks Moving In Friday’s Intraday Session

HC Wainwright & Co. Reiterates Buy on electroCore, Raises Price Target to $7

Earnings Scheduled For March 8, 2023